Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Ketamine: A Breakthrough in Psychiatric Treatment Offers Hope for Patients

Golden, CO (Newsworthy.ai) Friday Dec 29, 2023 @ 7:00 AM Eastern —

Unlike traditional antidepressant and antianxiety medications that primarily target serotonin, norepinephrine, and dopamine, ketamine focuses on glutamate pathways.

Incorporating ketamine into treatment plans has been particularly beneficial for patients who have not responded well to other medications. According to extensive research, up to 70% of individuals treated with ketamine, especially when complemented with therapy, have experienced notable improvements in their conditions.

"Ketamine has been a game-changer for many of my patients, especially those who have struggled to find relief with other treatments," stated Dr. Jane Summers, a renowned psychiatrist. "Its unique mechanism of action on glutamate, combined with the right therapeutic approach, has proven tremendously beneficial in helping individuals regain control of their mental health."

When administered by trained professionals, ketamine treatment is considered safe. Nonetheless, it is essential to note that there are rare instances of severe side effects, such as elevated blood pressure, difficulty breathing, and allergic reactions. Individuals with specific medical conditions should not utilize ketamine as a treatment option. However, common side effects, including nausea, dizziness, impaired coordination, and drowsiness, are minimal.

"Patients must recognize the importance of obtaining ketamine treatment through qualified healthcare providers," cautions Dr. Summers. "A thorough assessment of medical history and consultation is essential to ensure a safe and appropriate course of action."

While there is potential for ketamine misuse when used recreationally or chronically, the prescribed and supervised administration of the drug significantly mitigates the risk of addiction. Importantly, patients need not discontinue their current psychiatric medications to explore ketamine treatment. To ensure a tailored treatment plan, it is strongly advised to consult with a healthcare provider before making any changes.

Ketamine is revolutionizing the field of psychiatric treatment, offering a new frontier of hope for those who have struggled with traditional medications. With its unique mechanism of action and remarkable success rates, this promising drug is reshaping the lives of individuals suffering from a range of mental health conditions.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Ketamine: A Breakthrough in Psychiatric Treatment Offers Hope for Patients.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.